Journal profile

Indonesian Journal of Rheumatology

ISSN 2086-1435 · eISSN 2581-1142 · Indonesia Rheumatology Association · Indonesia

Indonesian Journal of Rheumatology: fully open access; APC about USD 150; review about 16 weeks (community reports); 7 articles in 2025.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartile—No CiteScore rank
Review timeabout 16 weeksCommunity average
APCUSD 150Fully open access
Acceptance—No reports yet
Articles per year72025 · OpenAlex count

Scope

Aims, scope and focus

Indonesian Journal of Rheumatology is published by Indonesia Rheumatology Association. By OpenAlex counts of its recent articles, its largest topics are Systemic Lupus Erythematosus Research, Systemic Sclerosis and Related Diseases and Rheumatoid Arthritis Research and Therapies, together about 46.4% of its articles. Its main subfields are Rheumatology and Pulmonary and Respiratory Medicine. (generated from OpenAlex topic counts and CAS ranking data)

Indonesian Journal of Rheumatology is a peer-reviewed open access journal on rheumatic diseases and connective tissue disorders. This is an official journal of Indonesian Rheumatology Association (IRA) and published twice a year since 2009. Our mission is to encourage the development of scientific and medical practice in rheumatic diseases and connective tissue disorders. This journal is self-focused on rheumatic disease and connective tissue disorders in the form of original article (extended and/or concise reports), review articles, editorial letters, leaders, lesson from memorable cases, book reviews, and matter arising. Both in clinical and laboratory including animal studies.

From the journal's Aims & Scope

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Systemic Lupus Erythematosus ResearchMedicine21%
  2. Systemic Sclerosis and Related DiseasesMedicine15.3%
  3. Rheumatoid Arthritis Research and TherapiesMedicine10.2%
  4. Vasculitis and related conditionsMedicine6.8%
  5. Gout, Hyperuricemia, Uric AcidMedicine4.1%
  6. Autoimmune and Inflammatory Disorders ResearchMedicine4.1%
  7. Pulmonary Hypertension Research and TreatmentsMedicine3.4%
  8. Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisMedicine3.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

DOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
4OpenAlex ·
i10-index
2OpenAlex ·
2-year mean citedness
0.05OpenAlex ·
Share of gold OA articles
0%LetPub ·

Articles by year OpenAlex count · 174 in total · the current year is incomplete

YearArticlesOpen accessCitations
202619198
20257710
2024292911
2023212119
2022121217
2021181816

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 16 weeksLetPub ·
Submission to publication (journal-reported)
about 16 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJUSD 150NoCC BY-NC
OpenAlexUSD 150——
LetPubUSD 150No—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
Indonesia Rheumatology Association
Country or region
Indonesia
Language
English
ISSN
2086-1435
Electronic ISSN
2581-1142
Latest issue on the website
Volume 18, Issue 1 (2026)
Official links

FAQ

Frequently asked questions about Indonesian Journal of Rheumatology

How long does peer review take at Indonesian Journal of Rheumatology?

Authors report an average review time of about 16 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Indonesian Journal of Rheumatology?

According to LetPub and DOAJ records, Indonesian Journal of Rheumatology is indexed in DOAJ.

Is Indonesian Journal of Rheumatology open access, and what is the APC?

Indonesian Journal of Rheumatology is a fully open-access journal. APC about USD 150.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .